Search Results

You are looking at 101 - 110 of 126 items for :

  • "Bladder cancer" x
Clear All
Full access

Emil Lou, Donna D'Souza and Andrew C. Nelson

1, 2016 . 17. Grimmond SM Raghavan D Russell PJ . Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing . Urol Res 1992 ; 20 : 121 – 126 . 18

Full access

Michelle C. Nguyen, Manisha H. Shah, David A. Liebner, Floor J. Backes, John Phay and Lawrence A. Shirley

–small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, head and neck squamous cell cancer, urothelial bladder cancer, and microsatellite-unstable tumors. Multiple clinical trials are currently underway to evaluate its effectiveness in other solid

Full access

Carlotta Palumbo, Francesco A. Mistretta, Sophie Knipper, Angela Pecoraro, Zhe Tian, Shahrokh F. Shariat, Fred Saad, Claudio Simeone, Alberto Briganti, Alessandro Antonelli and Pierre I. Karakiewicz

after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time . Eur Urol 2014 ; 66 : 361 – 370 . 10.1016/j.eururo.2013.09.050 24139235 9. Henson DE , Ries LA , Carriaga MT . Conditional survival of 56

Full access

Arti Hurria, Ilene S. Browner, Harvey Jay Cohen, Crystal S. Denlinger, Mollie deShazo, Martine Extermann, Apar Kishor P. Ganti, Jimmie C. Holland, Holly M. Holmes, Mohana B. Karlekar, Nancy L. Keating, June McKoy, Bruno C. Medeiros, Ewa Mrozek, Tracey O’Connor, Stephen H. Petersdorf, Hope S. Rugo, Rebecca A. Silliman, William P. Tew, Louise C. Walter, Alva B. Weir III and Tanya Wildes

Guidelines for AML in centers skilled in the management and supportive care of AML (to view the most recent version of these guidelines, visit the NCCN Web site at www.NCCN.org ). Bladder Cancer: Intravesical immunotherapy with Bacillus Calmette

Full access

-054 jnccn20197460 10.6004/jnccn.2019.7460 CLO20-055: Optimal Timing of Radical Surgery From Diagnosis in Muscle Invasive Bladder Cancer (MIBC) Parasramka Saurabh MD Chen Quan DrPH Huang Bin DrPH., MS Wang Peng MD, PhD Myint Zin MD 20 03 2020 18 18 3.5 3

Full access

Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska and William J. Mackillop

-invasive bladder cancer: a population-based outcomes study . Cancer 2014 ; 120 : 1630 – 1638 . 11. Meyer RM . Generalizing the results of cancer clinical trials . J Clin Oncol 2010 ; 28 : 187 – 189 . 12. Booth CM Mackillop WJ

Full access

Emily J. Guerard, Allison M. Deal, YunKyung Chang, Grant R. Williams, Kirsten A. Nyrop, Mackenzi Pergolotti, Hyman B. Muss, Hanna K. Sanoff and Jennifer L. Lund

study . Crit Rev Oncol Hematol 2010 ; 76 : 208 – 217 . 33. Chappidi MR Kates M Patel HD . Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy . Urol Oncol 2016 ; 34 : 256.e1 – 6

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Don Dizon, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, Muhammad Raza, M. Alma Rodriguez, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian and Deborah A. Freedman-Cass

. Wyszynski A Tanyos SA Rees JR . Body mass and smoking are modifiable risk factors for recurrent bladder cancer . Cancer 2014 ; 120 : 408 – 414 . 7. Hudis CA Jones L . Promoting exercise after a cancer diagnosis: easier said than done . Br J

Full access

David Cella, Sarah K. Rosenbloom, Jennifer L. Beaumont, Susan E. Yount, Diane Paul, Debra Hampton, Amy P. Abernethy, Paul B. Jacobsen, Karen Syrjala and Jamie H. Von Roenn

other primary malignancy diagnosed or treated within the previous 5 years, excluding nonmelanoma skin cancer. A total of 533 patients participated in the study, with approximately 50 patients per disease site except for bladder cancer (n = 31). Table 1

Full access

Michael Xiang and Elizabeth A. Kidd

, Shipley WU , . Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233 . J